Education
About Us
Working with TipRanks
Follow Us
Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170)
:2170
2170 Stock Chart & Stats
HK$2.13
HK$0.20(8.26%)
At close: 4:00 PM EST
HK$2.13
HK$0.20(8.26%)
Day’s Range― - ―
52-Week RangeHK$2.00 - HK$4.45
Previous CloseN/A
Volume107.50K
Average Volume (3M)121.73K
Market Cap
HK$588.08M
Enterprise ValueHK$551.32M
Total Cash (Recent Filing)HK$545.48M
Total Debt (Recent Filing)HK$342.23M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding82,713,840
10 Day Avg. Volume98,950
30 Day Avg. Volume121,733
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)0.62
Price to Sales (P/S)2.35
P/FCF Ratio-2.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Suzhou Basecare Medical Corp. Ltd. Class H News
2170 FAQ
What was Suzhou Basecare Medical Corp. Ltd. Class H’s price range in the past 12 months?
Suzhou Basecare Medical Corp. Ltd. Class H lowest stock price was HK$2.00 and its highest was HK$4.45 in the past 12 months.
What is Suzhou Basecare Medical Corp. Ltd. Class H’s market cap?
Suzhou Basecare Medical Corp. Ltd. Class H’s market cap is HK$588.08M.
When is Suzhou Basecare Medical Corp. Ltd. Class H’s upcoming earnings report date?
Suzhou Basecare Medical Corp. Ltd. Class H’s upcoming earnings report date is Mar 26, 2026 which is in 97 days.
How were Suzhou Basecare Medical Corp. Ltd. Class H’s earnings last quarter?
Suzhou Basecare Medical Corp. Ltd. Class H released its earnings results on Aug 29, 2025. The company reported -HK$0.441 earnings per share for the quarter, the consensus estimate of -HK$0.441 by HK$0.
Is Suzhou Basecare Medical Corp. Ltd. Class H overvalued?
According to Wall Street analysts Suzhou Basecare Medical Corp. Ltd. Class H’s price is currently Overvalued.
Does Suzhou Basecare Medical Corp. Ltd. Class H pay dividends?
Suzhou Basecare Medical Corp. Ltd. Class H does not currently pay dividends.
What is Suzhou Basecare Medical Corp. Ltd. Class H’s EPS estimate?
Suzhou Basecare Medical Corp. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Suzhou Basecare Medical Corp. Ltd. Class H have?
Suzhou Basecare Medical Corp. Ltd. Class H has 82,713,840 shares outstanding.
What happened to Suzhou Basecare Medical Corp. Ltd. Class H’s price movement after its last earnings report?
Suzhou Basecare Medical Corp. Ltd. Class H reported an EPS of -HK$0.441 in its last earnings report, expectations of -HK$0.441. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Suzhou Basecare Medical Corp. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2170
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Suzhou Basecare Medical Corp. Ltd. Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.08%
12-Months-Change
Fundamentals
Return on Equity
-20.60%
Trailing 12-Months
Asset Growth
-11.13%
Trailing 12-Months
Company Description
Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corp. Ltd. Class H (2170) is a prominent healthcare company based in China that specializes in the development, manufacturing, and commercialization of advanced medical devices and diagnostic solutions. The company operates primarily in the fields of medical imaging, in vitro diagnostics, and healthcare information technology. With a strong focus on innovation, Basecare aims to enhance patient care through its cutting-edge products and services designed to improve clinical outcomes across various medical disciplines.
Technical Analysis
Peijia Medical Ltd.
―
MicroPort CardioFlow Medtech Corp.
―
Broncus Holding Corp.
―
MicroTech Medical (Hangzhou) Co., Ltd. Class H
―
Venus Medtech (Hangzhou), Inc. Class H
―